Drugs / U3-1784
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02690350 | Feb 2016 → Feb 2017 | hepatocellular carcinoma | Daiichi Sankyo | Terminated | No outcome recorded Stop: Business |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | U3-1784 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02690350 ↗ |